©2012 - NDI Medical
 
Portfolio
print
 

SPR Therapeutics


SPR™ Therapeutics (Stimulation for Pain Relief) was spun-out from NDI in January, 2010 and is developing and bringing to market its patented peripheral nerve stimulation (PNS) products for the treatment of pain.

Its first product, the SMARTPATCH™ uses a proprietary method of Intramuscular Nerve (IMN™) Therapy, which stimulates nerves within the muscle to treat the pain. It is non-narcotic, non-surgical, and easily deployed.

Its next product is a two-stage PNS system for the treatment of chronic pain, using the SMARTPATCH™ short-term trial system in the first stage, and a fully implantable MICROPULSE® long-term implant system in its second stage.

The company’s pain therapies represent an estimated $20 billion market size.

For more information on SPR™ Therapeutics, visit: www.sprtherapeutics.com

Premarket notification (510(K)) pending for the Smartpatch™ PNS System. Not available for sale. CAUTION: The Micropulse® System is an investigational device. Limited by Federal law to investigational use. Not available for sale.